Advancements: The FDA approved the Phase 1a accelerated dose-escalation design based on extensive research, prior clinical testing, and the safety profile of fenretinide in more than 3,000 patients. This accelerated portion of the trial is designed...
either prior to VILTEPSO infusion, or at least 48 hours after the most recent infusion. Alternatively, use a laboratory test that does not use the reagent pyrogallol red, which has the potential to generate a false positive result due to cross...
analysis using T1-weighted images derived from MRI scans, specifically targeting neurodegeneration conditions. The latest clearance extends the software's capabilities, incorporating advanced analysis of MS and white matter hyperintensities (WMH)...
The latest progress in the clinical trial of BH3120, an innovative immunotherapy jointly developed by Hanmi Pharmaceutical and Beijing Hanmi Pharmaceutical, was recently presented at a major global academic conference, drawing significant...
muscles and other tissues (causing respiratory problems, fatigue, hypersomnia, cardiac abnormalities, severe gastrointestinal complications, and cognitive and behavioral impairment). Most commonly, it manifests during adulthood (classic DM1)....
PSMA PET tracers, such as 18F- and 68Ga-based products, restricts their use. "This milestone with the AMPLIFY trial is a testament to the hard work of our team and collaborators. We would like to thank all clinicians and patients who participate in...
has shared the intended Phase 2 study design with regulators and, subject to trial safety committee agreement, will test innovative dosing regimens in the Phase 2 study. Based on the advantageous results for absolute tumour and normal organ uptake...
and government research, forensics, pharmaceuticals, clinical diagnostics and veterinary, agricultural and environmental testing. Promega is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. For more...
their new comprehensive assessment and research center, nuHx, and Marius Pharmaceuticals, the company behind KYZATREX® (testosterone undecanoate) CIII capsules, an FDA-approved oral testosterone treatment for men. Together, they aim to conduct a...
from Mouldflo. Material preparation and feeding is ensured by a system from motan colortronic. HB-Therm provides the latest generation of Thermo 6 temperature control units. System partner SKA is providing the fully automatic handling system...
provision that requires the Secretary of Health and Human Services to conduct a study and provide a report to Congress on testing, preventative care, precision medicine and treatment for rare kidney disease. Advocates will also urge members of...
they disintegrate almost immediately in the stomach. The small drug particles then flow from the stomach and through the intestines. However, many cancer drugs are only absorbed into the bloodstream in the upper, acidic part of the gastrointestinal...
significant 20% increase in whole blood NAD+ levels three hours post-infusion, as measured by NAD+ dried blood spot tests (MedRxiv). Impact Health Medical, Fountain Life, The Remedy Room, and VYVE Wellness celebrate the launch of Niagen+: Halland...
BeiGene, Ltd. a global oncology company, today announced it will share new data for TEVIMBRA® (tislelizumab).“TEVIMBRA has shown potential across multiple disease states, and the data at further supports its position as the foundational asset of...
external innovation. The integrations aim to offer a comprehensive suite of digital pathology tools that enhance biomarker testing for cancer research and improve patient outcomes through precision medicine. The collaboration spans significant...
on several endpoints versus placebo, including SSc symptoms of overall disease severity, disease-related pain, gastrointestinal dysfunction, skin ulcers, disability, and breathing symptoms, as well as Raynaud's symptoms. In a preliminary review by...
that they have entered into a long-term commercial agreement for the exclusive distribution of the Bladder EpiCheck® test in Europe. This non-invasive CE-marked test detects primary or recurrent bladder cancer and upper tract urinary cancer....
over 100 years of IKA`s expertise and our commitment to putting our customers at the center of everything we do. Our latest accessories and sensors, introduced based on customer feedback, improve the bioreactor's efficiency, reliability, and...
the world leader in innovative technologies enabling high-throughput biology, today has launched Carterra Ultra™—the latest addition to its LSA® and LSAXT label-free high-throughput surface plasmon resonance (HT-SPR) instruments. The Ultra platform...
Award at The Rockefeller University as a postdoctoral fellow where she studied small molecules made by the human gastrointestinal microbiome. "I'm passionate about the transformative potential of innovation leveraging a systems biology approach to...
